BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Hybridon Incorporated

Hybridon is a leader in the discovery and development of genetic drugs. These drugs are based on "antisense" technology which uses synthetic RNA and DNA that are designed to treat the underlying cause of disease by stopping or reducing the body's production of proteins that directly or indirectly cause disease. Hybridon also manufactures and sells synthetic RNA and DNA, also called oligonucleotides, to third parties on a contract basis. Hybridon's leadership in the antisense field is based on oligonucleotide technology it owns or exclusively licenses, including (a) new advanced chemistries, (b) sequence selection know-how, (c) drug development know-how, (d) innovations in the manufacturing process, (e) its fully integrated, large scale manufacturing facility and (f) its experience in manufacturing over 300 different compounds with various chemical modifications.


Contact Details:
620 Memorial Drive
Cambridge
MA
02139
United States of America
Tel:617 528 7000
Fax:617 528 7001
Email:
WWW:

www.hybridon.com/




Loading...

Recent Publications by Hybridon Incorporated:

Chemistry of CpG DNA.
The vertebrate immune system can recognize specific pathogen-associated...
28th May, 2008
Hybridon, Inc., Cambridge, Massachusetts, USA. Curr Protoc Nucleic Acid Chem. 2003 May;Chapter 4:Unit 4.16.
DOI Direct Link
Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice.
Toll-like receptor 9 (TLR9) modulators have potent Th1-adjuvant activity....
16th August, 2005
Hybridon, Inc., 345 Vassar Street, Cambridge, MA 02139-4818, United Int Immunopharmacol. 2005 Jun;5(6):981-91.
DOI Direct Link
Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Bacterial DNA and synthetic oligomers containing CpG dinucleotides...
2nd August, 2005
Hybridon, Inc., 345 Vassar Street, Cambridge, MA 02139, USA. Proc Natl Acad Sci U S A. 2005 May 10;102(19):6925-30. Epub 2005 Apr 28.
DOI Direct Link
Oral administration of second-generation immunomodulatory oligonucleotides induces mucosal Th1 immune responses and adjuvant activity.
CpG DNA induces potent Th1 immune responses through Toll-like receptor 9....
15th July, 2005
Hybridon, Inc., 345 Vassar Street, Cambridge, MA 02139, USA. Vaccine. 2005 Apr 8;23(20):2614-22.
DOI Direct Link
Role of Toll-like receptors in antisense and siRNA [corrected]
About 25 years ago, researchers first demonstrated that a short synthetic...
13th April, 2005
Hybridon, Inc., 345 Vassar Street, Cambridge, Massachusetts 02139, USA. Nat Biotechnol. 2004 Dec;22(12):1533-7.
DOI Direct Link

View more Hybridon Incorporated research publications.

Hybridon Incorporated Patents:

US Patent No.Title
5833944 Procedure for the solid phase synthesis of .sup.35 S-labeled oligonucleotides with 3H-1,2-benzodithiol-3-one-1,1-dioxide
5969117 Modified protein kinase a-specific oligonucleotide
5973136 Inverted chimeric oligonucleotides
6013786 MDM2-specific antisense oligonucleotides
6054439 Antisense olignucleotides having tumorigenicity-inhibiting activity

View more Hybridon Incorporated patents.

Hybridon Incorporated (HBY) Financial information Links from Barchart

HBY Quote from from Barchart.com
HBY Chart from from Barchart.com
HBY Profile from from Barchart.com
HBY Opinion from from Barchart.com

View more Hybridon Incorporated finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 33 individuals from Hybridon Incorporated using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 254 times since April 2007, the link to the organisation's website has been followed 71 times

Recent Search Terms used to find this page: Hybridon | hybridon.com | hybridon | Hybridon Incorporated | hybridon | hybridon | Hybridon | www.hybridon.com | hybridon.com | hybridon | .

Search for more companies in Cambridge

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Hybridon Incorporated
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.